Insulin prices are soaring, creating pain for patients whose life depends on the injectable drug; yet most of the revenue from the increases isn't going to the drug manufacturers, it is largely being collected by the middlemen.
Insulin Prices Soar While Drugmakers’ Share Stays Flat
Comment
Show comments
Hide Comments
